Safety Communication

 Read More

Dear Healthcare Professional,

As part of Risk Management Plan (RMP) conducted by pharmaceutical industry, PT Roche Indonesia communicate safety information for doctor related to Esbriet (Pirfenidone).

Esbriet (Pirfenidone) is medicine for mild to moderate Idiopathic Pulmonary Fibrosis (IPF) in adult. This safety information contains important elements for Esbriet (Pirfenidone) use especially related to photosensitivity and hepatic function.

 Read More

Dear Healthcare Professionals,

Related to safety issue of drug containing Policresulen concentrate liquid for external use, please find the link for NADFC regulatory action on 15 February 2018 as follow:

 https://www.pom.go.id/new/view/more/klarifikasi/80/PENJELASAN-BPOM-RI--TERKAIT-ISU-KEAMANAN-OBAT-MENGANDUNG-POLICRESULEN-CAIRAN-OBAT-LUAR-KONSENTRAT.html

 Read More

Dear Healtcare Professionals,

 

Related Dengvaxia vaccine safety issue (dengue vaccine) published in the media regarding the suspension of use of the Dengvaxia Vaccine (dengue vaccine) in immunization programs in the Philippines, the results of an explorative study are :

 Read More

 Read More

Poll
How do you think the content and appearance of this website?




logo dsras Email Rapid Alert System

Selamat email anda telah berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia.

 

logo dsras Email Rapid Alert System

Anda ingin berhenti berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia?